ReviewFrontiers in pharmacology2022

Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?

Rebecca F Budgett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.